Breakthrough in Science for Durable Vaccines

Researchers from Monash University’s Central Clinical School have made a groundbreaking discovery in vaccine efficacy published in the journal Immunity. They identified a unique subtype of immune cell capable of producing antibodies indefinitely, which holds the key to long-lasting immunity post-vaccination. Their study revealed that the body can only maintain a finite number of these durable cells, primarily located in the bone marrow. This finding could transform how vaccines are developed, shifting the focus towards preserving these long-lived immune cell reservoirs.
The variability in vaccine efficacy, exemplified by the need for regular COVID-19 boosters compared to decades-long protection from measles vaccinations, has posed a scientific conundrum. Professor David Tarlinton and Dr. Marcus Robinson led the research, using an animal model to study the lifespan and characteristics of antibody-secreting cells, identifying specific markers associated with longevity. They noted that enhancing vaccines to promote these long-lasting cells could improve immune responses. Ultimately, the research suggests that future vaccines should aim to sustain these immune cell reservoirs to achieve enduring protection against infections.
https://instegro.net/breakthrough-in-science-for-durable-vaccines/?fsp_sid=57229
Yorumlar
Yorum Gönder